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Noninvasive Quantification of the Differential Portal
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Abstract—Our recent research has demonstrated that 11C-ac-
etate could be a complementary tracer to 18F-fluorodeoxyglucose
(FDG) in positron emission tomography (PET) imaging of hep-
atocellular carcinoma (HCC). In our previous modeling study, a
three-compartment four-parameter model with a fixed contribu-
tion ratio of the liver’s two blood supplies was proposed to charac-
terize the kinetic behavior of 11C-acetate in liver. However, in real
pathology, both tumor and nontumor liver tissue can be heteroge-
neous in the distribution and proportion of the two blood supplies.
To further improve the accuracy of quantitative analysis, the actual
proportion of the hepatic artery and portal vein (PV) in different
regions of interest (ROIs) was investigated in this study. An extra
parameter was included in the model input function to describe
the contribution of PV to the liver. Ten ROIs extracted from six pa-
tients were used to test the models with fixed/nonfixed weighted
dual-input function. The weighted nonlinear least squares algo-
rithm was used to estimate all of the parameters. Evaluation of the
adequacy of the two models was conducted and the computer sim-
ulation was performed to test the estimation accuracy of the new
model. The forward clearance was also estimated by the linear
Patlak method. The results show that the model with parameter
in the input function was more suitable for mapping the tracer
time activity curves. Moreover, the estimated value fits the prac-
tical physiological and pathological conditions well and could be a
potential candidate to provide useful additional diagnostic infor-
mation for the early detection of hepatic metastases.
Index Terms—Dual-input function, noninvasive measurement,
parameter estimation, positron emission tomography (PET),
tracer kinetic modeling.
I. INTRODUCTION
HEPATOCELLULAR carcinoma (HCC) is the most fre-quent malignant tumor of the liver. Patients with HCC
are often unaware of its presence until the tumor has reached
an advanced stage [1] and less than 10% are cured with sur-
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gical resection. The overall five-year survival rate for late de-
tection is less than 5% [2], [3]. It is important to detect HCC
at its early stage for curative treatment. Positron emission to-
mography (PET) enables extracting quantitative physiological
information in vivo from complex dynamic processes by using
the tracer kinetic modeling techniques, which makes it useful
for early detection of malignant tumors.
F-fluorodeoxyglucose (FDG) PET is well established for
measurements of many physiological parameters. However,
40%–50% of HCC are not FDG-avid. Our recent research has
demonstrated that C-acetate could be a complementary tracer
to FDG in PET imaging of HCC [4], [5]. To get a better un-
derstanding of the characteristics of C-acetate in the imaging
of HCC in the liver, quantitative dynamic modeling has been
conducted [5], in which a three-compartment four-parameter
(4P) model was presented and a new physiological param-
eter called “local hepatic metabolic rate-constant of acetate
(LHMRAct)” was introduced to characterize the regional
consumption of acetate by HCC and nontumor liver tissue. The
tracer time-activity curve in blood (BTAC) was used as the
model input function. To account for the liver’s dual source
of blood supply from the hepatic artery (HA) and portal vein
(PV), we initially assumed a fixed contribution ratio of HA and
PV in formulating the input function, viz. 20% contribution
from HA and 80% from PV according to their approximate
percentage perfusion to the nontumor liver tissue, 80% or 100%
contribution from HA for HCC due to the generally accepted
fact that the majority of the blood supply to established liver
metastases is derived from the HA [1], [6], [7]. However, early
stage metastases may not be easily differentiated on dynamic
PET images, therefore, it may be difficult to choose the fixed
weight for quantitative study. Furthermore, in real pathology,
both the tumor and nontumor liver tissue can be heterogeneous
in the distribution and proportion of the two blood supplies.
Small liver tumors ( mm) are mainly fed by PV, while for
larger tumors, these lesions receive up to 95% of their blood
supply from HA [8]. For nontumor liver tissue, the two blood
supplies may also vary within the liver and among individual
patients due to many factors. Various liver diseases alter hepatic
arterial circulation [9]. HCC is associated with liver cirrhosis
in 80% of cases [6]; it is stated that normal liver parenchyma
obtains about 75% of its blood supply from the PVs and 25%
from the HAs, whereas in cirrhotic livers the blood supply
0018-9294/04$20.00 © 2004 IEEE
Authorized licensed use limited to: Hong Kong Polytechnic University. Downloaded on June 25,2010 at 03:56:13 UTC from IEEE Xplore.  Restrictions apply. 
1580 IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 51, NO. 9, SEPTEMBER 2004
is obtained from the arteries in a proportion up to 75% [7].
The presence of regenerating and dysplastic nodules will also
change the liver blood supply. Therefore, the fixed weighted
dual-input function would increase the statistical uncertainties
and reduce the accuracy in the estimated model parameters.
The actual proportion of the two blood supplies in different
regions of interest (ROIs) is needed to achieve more accurate
quantitative analysis. In addition, measurement of the relative
PV or HA contribution to liver blood flow might provide an
alternative method for the detection of liver tumors [7].
Various kinds of methods have been used to distinguish
PV and HA distribution. Direct measurements usually involve
cannulation procedures which are very invasive and always
performed on anaesthetized animals [10], [11]. Breedis and
Young [12] injected dyes and plastic into the blood vessels for
postmortem studies. Later, Lin et al. [13] used colored silicone
rubber injected into the PV and HA to determine the different
distribution. All of these techniques are too invasive to perform
on humans. Alternative noninvasive techniques are, therefore,
of great interest.
Sarper et al. [14] presented a noninvasive indirect measure-
ment by using dynamic scintigraphy: measuring the first pass of
an intravenous bolus injection of a radioactive colloid through
the liver and kidney to obtain the hepatic perfusion index (HPI)
from the time-activity curve (TAC) of the liver [7]. However,
this technique is well recognized to be susceptible to numerous
errors in the derivation of the index, such as the overlap of the
hepatic arterial and portal venous phases and the presence of
intrahepatic portosystemic shunting [7]. Chen et al. [15] has re-
ported noninvasive quantification of hepatic arterial blood flow
with nitrogen-13-ammonia and dynamic PET. All these tech-
niques require extra examination and processing time and would
cause more discomforts to the patients. Additionally, it is impos-
sible to obtain the real-time PV and HA distribution during the
PET scan.
In this study, we study the feasibility of including an extra
parameter in the vascular input function of a C-acetate liver
model to obtain the differential portal and arterial contribution




The study population comprised six subjects, all of whom
were hepatitis B carriers, including two with HCC. The
transaxial (septa extended) dynamic PET images were obtained
on an ECAT-EXACT 47 PET scanner (CTI/Siemens, Inc.,
TN, USA), which simultaneously recorded 47 contiguous
planes. Each patient was positioned to allow image acquisition
of the liver dome and apical half of the left ventricle to the
inferior part of the liver. A Hanning filter was used for image
reconstruction, resulting in an in-plane spatial resolution of
4.119 mm. The axial resolution was 3.375 mm.
Serial images were obtained immediately following bolus IV
injection of C-acetate. The dynamic sequence consisted of ten
frames of 4 s, eight frames of 10 s, two frames of 30 s, three
frames of 60 s, and two frames of 120 s, totaling 25 frames for
a total scan time of 10 min.
B. Image Analysis
ROIs were defined using a single transverse slice of the full
sets of dynamic C-acetate images. Ten regions of dynamic
datasets, two from HCC regions, others from nontumor liver
regions, were extracted. In general, tracer kinetic modeling with
PET requires the measurements of both BTAC and the tracer
time-activity curve in tissue (TTAC) to quantitatively estimate
the model parameters, using BTAC and TTAC as the input and
output functions in the kinetic model. Although the arterial
blood measurements are considered to be the most accurate
representation of the BTAC and arterialized venous samples
have been validated as a replacement of arterial samples [16],
it is generally accepted that the insertion of arterial lines and
the subsequent collection and processing of arterial blood are
not compatible with the practice of clinical PET [17]. More-
over, it is highly invasive and virtually impossible in clinical
settings to count the radioactivity of the portal venous blood
by direct catheterization and sampling [5]. Therefore, in this
study, the TACs of both HA and PV were evaluated using the
image-derived method described in [5]. The PVs are small in
size and not very distinguishable from the surrounding tissue,
our newly proposed two-step segmentation method based on
cluster analysis was also used to facilitate the extraction of the
PV region [18].
C. C-Acetate Liver Model With a Nonfixed Weighted
Dual-Input Function
The C-acetate liver model was shown in Fig. 1. The differ-




where are the rate constants, is the C-acetate
concentration in the whole blood, is the free C-acetate
concentration in intracellular space, is the intracellular
products/metabolites concentration, and is the sum of
and . As seen in Fig. 1, another parameter hepatic blood
volume (HBV) was included in the model to account for the
contribution of the tracer within vascular/sinus space of the liver
tissue to the observed total tissue activity; then the observed total
tissue activity is given by
(4)
The solution of in terms of macroparameters is
(5)
where
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Fig. 1. Three-compartment liver kinetic model for C-acetate with an extra parameter in the dual-input function. Typical TACs of HA and PV were illustrated
in the BTAC measurements. The last five points of PV measurements were replaced by the corresponding HA data. Solid line marked by an asterisk stands for the
HA, triangle for the PV. The greatest activity difference between these two curves is during the early radionuclide angiographic phase. Typical TACs of nontumor
liver tissue and HCC were illustrated in the TTAC measurements. Solid line marked by an asterisk stands for the nontumor liver tissue, triangle for the HCC.
are the macroparameters in the C-acetate liver model and
denotes the operation of temporal convolution.
In this study, to obtain the proportion of the portal or arterial
contribution to the liver blood supply and provide more accurate
physiological parameter estimates, a new parameter was in-
cluded in the model input function to describe the contribution
of PV. Therefore, the contribution of HA would be .
Thus, the dual-input function was calculated according to
(6)
where is the tracer concentration in the HA and is




D. Parameter Estimation and Statistical Analysis
Three-compartment 4P model with parameter in the dual-
input function was used to fit the clinical data and compared
with the fitting results of the 4P model using fixed weighted
dual-input function. With the measurements of , and
from dynamic PET images, the weighted nonlinear least
squares (NLS) algorithm was used to numerically evaluate all of
the individual parameters. Model parameters were estimated by
minimizing the weighted residual sum of squares (WRSS) [11],
which is a direct measurement of the fitting quality. WRSS is
given by
(8)
where is the vector of parameters to be estimated, is
the weight adopted, which is proportional to the length of the
scanning interval and inversely proportional to the radioactivity
concentration, is the model output, which is a function of
, and is the PET measurement. The superscript 25 is the
total data points to be fitted in this study. LHMRAct could be
calculated by
(9)
from NLS fitting results.
Patlak analysis [19] was also provided to estimate LHMRAct
for the two models to fit the data between 2.5–10 min. Since the
Patlak method could not estimate parameter , for the nonfixed
weighted dual-input model the input function was calculated
according to the estimated value of by using NLS method.
The estimated LHMRAct of both models were compared with
those obtained from the NLS method, respectively, by correla-
tion analysis.
Apart from WRSS, parameter standard deviation (SD) and
coefficient of variation (CV), which are the computed measure-
ments of variability of parameter estimation, were utilized as
the statistical criteria. In addition, Akaike Information Criteria
(AIC) [20] and Schwarz Criteria (SC) [21] were used to test
which model is better. It was assumed that the data variances
were known up to a proportionality constant; therefore, the AIC
and SC are given by
(10)
(11)
where is the number of parameters in the model, and is the
number of data points.
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TABLE I
ESTIMATED PARAMETERS OF THE THREE-COMPARTMENT 4P C-ACETATE
LIVER MODEL WITH 70% CONTRIBUTION FROM PV USING THE NLS METHOD
TABLE II
ESTIMATED PARAMETERS OF THE THREE-COMPARTMENT 4P C-ACETATE
LIVER MODEL WITH 80% CONTRIBUTION FROM PV USING THE NLS METHOD
E. Simulation Study
Computer simulation was also conducted to test the ac-
curacy and reliability of the estimated parameters of the
nonfixed weighted dual-input model. The TACs of both
PV and HA were extracted from one clinical dataset.
The TTAC was calculated according to (4) by using
.
The scanning intervals were the same as those in clinical data
acquisition. A pseudorandom number generator was used to
generate the Gaussian noise added to the calculated TTAC, and
the noise level was set to 0.1, 0.5, and 1.0, respectively. The
mean value of the estimated parameters was calculated from
100 simulation runs, and the bias was calculated by
(12)
where is the true value of the parameter and is the mean
value from the NLS fitting results of the computer simulation.
III. RESULTS AND DISCUSSION
The C-acetate clinical data of ten ROIs extracted from six
patients were analyzed to test the models a with fixed/nonfixed
weighted dual-input function. The estimated results of the
models with 70%, 80%, and 85% contribution from PV were
shown in Tables I–III, respectively. The parameter estimates
for the model with a nonfixed weighted input were summarized
TABLE III
ESTIMATED PARAMETERS OF THE THREE-COMPARTMENT 4P C-ACETATE
LIVER MODEL WITH 85% CONTRIBUTION FROM PV USING THE NLS METHOD
TABLE IV
ESTIMATED PARAMETERS OF THE THREE-COMPARTMENT 4P C-ACETATE
LIVER MODEL WITH AN EXTRA PARAMETER a IN THE DUAL-INPUT
FUNCTION USING THE NLS METHOD
in Table IV. In Table II, 100% and 80% contribution from HA
for regions 7 and 10, respectively, were used; 60% contribution
from HA was adopted for regions 7 and 10 in Table III.
Comparison of the three groups of estimation results according
to CV and WRSS (contained in Table V) was conducted. It
could be found that, among the ten datasets, half of the best
fitting results are from Table I, whereas the remaining half are
almost all from Table III. If the datasets achieving best fitting
are from Table I, they always show the worst fitting quality
in Table III. On the contrary, if the datasets of best quality
are from Table III, they always demonstrate the worst fitting
results in Table I. The estimated parameters in Table II exhibit
moderate fitting quality.
The estimation results in Table IV demonstrate that the es-
timated value shows moderate variability among different
ROIs from nontumor liver tissue and significant difference be-
tween HCC and nontumor regions . Therefore, a
nonfixed weighted input function has significant importance to
the parameter estimation. The fitting result of is very reli-
able since the CVs of five ROIs are less than 10%, three are
less than 20% and the other two are 65.46% and 45.87%, re-
spectively. The mean value of the estimated for nontumor
regions is 0.793, which is comparable with our previous hy-
pothesis and the SD is 0.104. The estimated value of the two
HCC ROIs is 0.363 and 0.590, which are much less than those
of the nontumor liver tissue. Regarding the comparison stated
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TABLE V
COMPARISON OF THE WRSS, AIC, AND SC OF THE MODELS USING A
FIXED/NONFIXED WEIGHTED DUAL-INPUT FUNCTION
in the above paragraph, for every dataset, the most accurate es-
timation among the three fixed-weight fittings is always with
the assumed weight that is closest to the estimated value in
Table IV. For example, the estimated value of regions 4 and
5 is 0.717 and 0.675 (shown in Table IV), respectively, for re-
gions 4 and 5, the model with 70% contribution from PV could
achieve best fitting quality compared with the other two weight
assumptions; the estimated value of region 9 is 0.882 (shown
in Table IV), for region 9, the model with 85% contribution from
PV could achieve most accurate estimation, which may indicate
that the estimated value could be accurate.
The fitting results using the fixed weights in Table II were
focused to be compared with those using a nonfixed weighted
input model. Compared with the results in Table II, the estimated
value of of nontumor regions in Table IV shows no
significant difference respectively, which may due to the fact
that the estimated value demonstrates relatively less variance
from 80%. For nontumor liver tissue, the mean value of is
0.662 ml/min/ml in Table II and 0.676 ml/min/ml in Table IV;
is 0.288/min in Table II and 0.296/min in Table IV; is
0.076/min in Table II and 0.077/min in Table IV. However, the
fitting results of the two HCC regions exhibit relatively great
difference especially for region 10, which may be due to the sig-
nificant difference between the estimated value and the fixed
weight assumed. It could be found that the two sets of estimated
HBV value in Tables II and IV differ greatly because HBV is
the hepatic blood volume term which is directly affected by the
contribution of the hepatic dual inputs. Since the vascularity of
a cirrhotic liver is heterogeneous, the estimated HBV value also
exhibits moderate variability [5].
Comparison of the WRSS, AIC, and SC of the fixed (weights
in Table II)/nonfixed weighted models was conducted, and the
results were summarized in Table V. The “WRSS change” term
in Table V was calculated by
% (13)
where is the WRSS using a nonfixed input model and
is the WRSS using a fixed input model. As shown
in Table V, when parameter was used, WRSS (refer to the
TABLE VI
COMPARISON OF THE CV OF THE ESTIMATED PARAMETERS IN
TABLES II AND IV
second column of WRSS change) for all regions except region
7 is reduced; all AICs except those of regions 3 and 7 are smaller
than those using the fixed weights in Table II, and region 10
shows no obvious improvement; all SCs except those of regions
3, 7, and 10 are smaller, and regions 8 and 9 show no obvious
improvement. It could be seen that most cases show that the 4P
model plus a weight parameter in the required model input func-
tion is the better model to characterize the kinetics of C-ac-
etate in the liver especially using AIC as the criteria. Although
AIC and SC are very similar, there is no guarantee that they
will indicate the same model as the best fit, especially when
the number of observations is large, say more than eight
[21], [22]. Therefore, the fitting result of the nonfixed weighted
model is satisfactory and parameter could be identified by
using the tracer kinetic modeling techniques.
Table VI demonstrates the comparison of the CV of the es-
timated parameters in Tables II and IV. Although there is one
more parameter in the nonfixed weighted input model, the CV
value is still acceptable: the mean CV value of the estimated
is 14.552%; is 26.856%; is 36.347%; HBV is 48.298%;
is 19.109%. About one third of the CVs of the estimated pa-
rameters (excluding ) even decrease, and the reliability of es-
timated is even improved. The model fitted curves according
to the fixed/nonfixed weighted input models for two datasets,
one from HCC and another from nontumor region, were shown
in Fig. 2.
The NLS fitting results of the computer simulation using a
nonfixed weighted dual-input model were involved in Table VII.
Parameter estimates were expressed as mean SD. As seen in
Table VII, both the CV and bias of all the estimated parameters
from 100 simulation runs are very small, therefore, reliable and
accurate parameter estimation of the nonfixed weighted dual-
input model could be achieved by using the NLS method.
The ten clinical datasets were also fitted with the Patlak
method using the fixed (weights in Table II)/nonfixed weighted
dual-input function. Due to the nature of the Patlak method,
the data of the early phase ( min) were not included in
the analysis. The results of the estimated forward clearance
for the two models using the NLS and Patlak methods were
presented in Table VIII. Since the TACs of the HA and PV are
similar after the dynamic phase [11], the estimated using
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Fig. 2. Graph shows the generated TACs of the HCC ROI with symbol “*” and the nontumor liver tissue ROI with symbol “.” Dashed lines demonstrate the
fitting results using the fixed weights (20% and 80% contribution from PV for HCC and nontumor regions, respectively) in the dual-input function; dotted lines
stand for the fitting results using an extra parameter in the input function of the C-acetate liver model.
TABLE VII
NLS FITTING RESULTS OF THE COMPUTER SIMULATION USING A NONFIXED WEIGHTED DUAL-INPUT MODEL. THE MEAN VALUE, SD, AND BIAS OF
K  k , HBV, a , AND KWERE CALCULATED FROM 100 SIMULATION RUNS
TABLE VIII
ESTIMATED K VALUE FOR THE MODELS WITH
FIXED (WEIGHTS IN TABLE II/NONFIXED WEIGHTED DUAL-INPUT FUNCTION
USING THE NLS AND PATLAK METHODS, RESPECTIVELY
the Patlak method is affected less by the input function, and the
nonfixed input model shows less difference with the fixed input
model. For the eight ROIs from the nontumor liver tissue, the
estimated value expressed as mean SD with/without is
0.1689 0.0160 and 0.1683 0.0154 ml/min/ml, respectively.
For the two ROIs of HCC, the estimated forward clearance
by the Patlak method with/without weight parameter is
0.2686 and 0.2644 ml/min/ml (region 7), 0.5187 and 0.4711
ml/min/ml (region 10). For NLS analysis, the results do
show some difference between the two models. For the eight
ROIs from the nontumor liver tissue, the estimated value
expressed as mean SD with/without is 0.1340 0.0186
and 0.1311 0.0222 ml/min/ml, respectively. For the two ROIs
of HCC, the estimated value with/without weight parameter
is 0.2997 and 0.2883 ml/min/ml (region 7), 0.5285 and 0.4790
ml/min/ml (region 10). The correlation coefficients between
the estimated value of the Patlak and NLS methods for
the fixed and nonfixed input models are 97.64% and 98.50%,
respectively. Just as in [5], the value of the non-FDG-avid
type of HCC (regions 7 and 10) is significantly higher than
those of the nontumor liver parenchyma . There-
fore, quantitative parametric imaging of LHMRAct may be a
potential functional imaging technique to detect HCC.
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IV. CONCLUSION
This study suggests that the differential portal and arterial
contribution to the liver blood supply could be extracted from
the PET dynamic measurements noninvasively using tracer ki-
netic modeling techniques. The estimated value is reason-
able and compatible with the clinical physiological and patho-
logical conditions. It may also add supportive evidence to the
viewpoint that liver metastases derive a much greater propor-
tion of their blood supply from the hepatic arterial flow and a
smaller proportion from the portal venous flow. In addition, the
estimated value might provide useful diagnostic information
to improve the early detection of liver tumors due to the fact that
the presence of even small liver tumors is associated with subtle
changes in the liver blood flow.
The present results show that all of the required parameters
can be quantified simultaneously and the parameter estimates
are reliable and accurate. The three-compartment 4P model
plus an extra weight parameter in the dual-input function is a
more appropriate representation of the system and suitable in
describing the kinetic characters of C-acetate in a 10-min
dynamic PET imaging of the liver. It allows more consistent
estimation of LHMRAct, which is considered as a potential
indicator for evaluating HCC. Therefore, this new model struc-
ture and modeling technique can provide a better description
of the C-acetate kinetic in liver, a better understanding of the
blood supply mechanism in liver and, thus, a better method for
the early detection of liver cancer.
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